688277: Announcement on the revision of the plan for issuing A-Shares to specific objects in 2021

Securities code: 688277 securities abbreviation: Tinavi Medical Technologies Co.Ltd(688277) Announcement No.: 2021-073 Tinavi Medical Technologies Co.Ltd(688277)

Announcement on the revision of the plan for issuing A-Shares to specific objects in 2021

The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law. Tinavi Medical Technologies Co.Ltd(688277) (hereinafter referred to as “the company”) held the 11th meeting of the 5th board of directors and the 5th meeting of the 4th board of supervisors on December 22, 2021, deliberated and adopted the proposal on adjusting the company’s plan to issue A-Shares to specific objects in 2021

<公司 2021年度向特定对象发行 A 股股票预案(修订稿)>

The company’s proposal on issuing A-Shares to specific objects in 2021 has been revised, and the main revisions are as follows:

Revision of sections of the plan

The special items for the investment items of the raised funds, the total investment amount of the raised funds and the relevant contents of the project investment amount have been updated

2、 The purpose of this issuance is revised to specific objects

Background and purpose of bank shares

Section 1 this time, the company issued and updated the summary items of the stock scheme issued by the targeted object of the raised funds investment project, the total amount of the raised funds investment and the summary amount of the project investment scheme to specific objects

7、 The issuance was approved

And the review procedures that need to be submitted for approval to update this offering

Procedure

Section II the board of directors updated the relevant contents of the investment items of the raised funds issued this time in the raised funds I, the use plan of the raised funds, the total investment amount of the raised funds and the feasible sub amount of the project investment

Analysis II. The investment project of raised funds updated the basic information of the investment project of raised funds issued this time, the contents of the feasibility analysis items and the relevant contents of the project investment amount

Section VI this time, the company issued and updated the impact of the diluted immediate return on the company’s main financial indicators and the total investment of the raised funds to the specific objects of the investment project of the raised funds issued this time

Impact and remedial measures

Revision of sections of the plan

Implementation and related commitments

The Tinavi Medical Technologies Co.Ltd(688277) 2021 plan for issuing A-Shares to specific objects (Revised Version) and relevant documents have been posted on the website of Shanghai Stock Exchange (www.sse. Com.. CN.) for disclosure, please pay attention to the majority of investors. The effectiveness and completion of matters related to the issuance of A-Shares to specific objects have yet to be reviewed by Shanghai Stock Exchange and reported to China Securities Regulatory Commission for registration. Please pay attention to investment risks.

It is hereby announced.

Tinavi Medical Technologies Co.Ltd(688277) board of directors December 24, 2021

 

- Advertisment -